Research programme: topical microbicides - Emory University/FemmePharmaAlternative Names: FP 1099
Latest Information Update: 29 Aug 2007
At a glance
- Originator Emory University; Georgia State University; Louisiana State University
- Developer FemmePharma
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 12 Feb 2004 Preclinical trials in HIV infections prevention in USA (Topical)